Market Overview
The companion animal health sector in the Middle East and Africa covers veterinary products and services designed for domesticated pets, primarily dogs, cats, horses, and companion birds. The market includes pharmaceuticals, biologics such as vaccines, and related healthcare products distributed through retail outlets and increasingly through e-commerce platforms. With a market value of approximately $480 million in 2025, the sector represents a significant and rapidly expanding segment of the broader animal health industry in the region.
- •Market valued at approximately $480 million in 2025 across Middle East and Africa regions
- •Products span pharmaceuticals and biologics distributed through retail and e-commerce channels
- •Primary companion animal categories include dogs, cats, horses, and pet birds
Growth Drivers
Increasing pet ownership rates across Gulf Cooperation Council countries and select African markets are fueling demand for companion animal health products and services. Rising disposable incomes and urbanization have contributed to the humanization of pets, with owners increasingly willing to invest in preventive care, routine vaccinations, and advanced treatments. Growing awareness of zoonotic diseases and the importance of animal health management has further accelerated market expansion and product adoption.
- •Rising disposable incomes and urbanization driving pet humanization trends across GCC
- •Expanding middle class population increasing spending on companion animal healthcare
- •Heightened awareness of zoonotic diseases and preventive veterinary medicine adoption
Segmentation and Regional Analysis
The market is segmented by animal type, with dogs and cats representing the largest companion animal segments, followed by horses and companion birds in smaller but stable categories. Product categories are divided between pharmaceuticals and biologics, while distribution occurs through traditional retail veterinary clinics and increasingly through e-commerce platforms. Geographically, GCC nations lead the market due to higher per-capita spending and developed veterinary infrastructure, though South Africa and other emerging African markets are showing growth potential.
- •Dogs and cats dominate the animal segment, with horses and companion birds as smaller categories
- •Product split between pharmaceuticals and biologics, with digital channels gaining distribution share
- •GCC countries lead regional market value, with South Africa and Nigeria emerging as growth markets
Trends and Outlook
What are the recent trends and outlook?
The market is expected to sustain its 9.14% annual growth trajectory through the early 2030s, driven by continued expansion of veterinary infrastructure and rising pet insurance adoption in key markets. Digital transformation of distribution channels, including online pharmacies and telemedicine consultations, is reshaping how veterinary products reach consumers across the region. The trend toward premium and specialty pet healthcare products, combined with improving regulatory frameworks in GCC markets, positions the sector for sustained long-term expansion.
- •Continued growth expected through 2033-2035 period across regional markets
- •Digital distribution channels and telemedicine gaining traction in GCC veterinary sector
- •Growing consumer demand for premium and specialized companion animal health solutions
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.